As All Existing Facilities Were Repurposed for the Manufacture of COVAXIN, with Continuous ... - Latest Tweet by ANI
The latest Tweet by ANI states, 'As all existing facilities were repurposed for the manufacture of COVAXIN, with continuous production during the past year, to meet the public health emergency of COVID-19, these upgrades were due: BharatBiotech'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)